Vistagen Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Vistagen Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$14.2M, a 110% decline year-over-year.
  • Vistagen Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$45.6M, a 27.4% decline year-over-year.
  • Vistagen Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$33M, a 44.3% increase from 2022.
  • Vistagen Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$59.3M, a 24% decline from 2021.
  • Vistagen Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$47.8M, a 166% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$45.6M -$14.2M -$7.45M -110% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$38.2M -$12.1M -$5.13M -73.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$33M -$11.4M +$880K +7.19% Jan 1, 2024 Mar 31, 2024 10-K 2024-06-11
Q4 2023 -$33.9M -$7.88M +$1.88M +19.3% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 -$35.8M -$6.78M +$10.7M +61.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$46.5M -$7M +$12.8M +64.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$59.3M -$12.2M +$4.45M +26.7% Jan 1, 2023 Mar 31, 2023 10-K 2023-06-28
Q4 2022 -$63.7M -$9.77M +$773K +7.33% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 -$64.5M -$17.5M -$4.69M -36.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$59.8M -$19.8M -$12M -155% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$47.8M -$16.7M -$10.5M -168% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-28
Q4 2021 -$37.3M -$10.5M -$5.24M -98.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-06-28
Q3 2021 -$32.1M -$12.8M -$9.51M -289% Jul 1, 2021 Sep 30, 2021 10-K 2023-06-28
Q2 2021 -$22.6M -$7.75M -$4.63M -148% Apr 1, 2021 Jun 30, 2021 10-K 2023-06-28
Q1 2021 -$17.9M -$6.22M -$2.96M -90.6% Jan 1, 2021 Mar 31, 2021 10-K 2021-06-29
Q4 2020 -$15M -$5.3M +$664K +11.1% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 -$15.6M -$3.29M +$2.06M +38.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$17.7M -$3.12M +$3.1M +49.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$20.8M -$3.26M +$2.46M +43% Jan 1, 2020 Mar 31, 2020 10-K 2021-06-29
Q4 2019 -$23.3M -$5.96M +$1.23M +17.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-06-29
Q3 2019 -$24.5M -$5.35M +$2.08M +28% Jul 1, 2019 Sep 30, 2019 10-K 2021-06-29
Q2 2019 -$26.6M -$6.22M -$2.01M -47.8% Apr 1, 2019 Jun 30, 2019 10-K 2021-06-29
Q1 2019 -$24.6M -$5.72M -$1.64M -40.3% Jan 1, 2019 Mar 31, 2019 10-K 2020-06-30
Q4 2018 -$22.9M -$7.19M -$4.32M -151% Oct 1, 2018 Dec 31, 2018 10-K 2020-06-30
Q3 2018 -$18.6M -$7.43M -$2.44M -48.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-06-30
Q2 2018 -$16.2M -$4.21M -$1.95M -86.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-06-30
Q1 2018 -$14.2M -$4.08M -$1.53M -60% Jan 1, 2018 Mar 31, 2018 10-K 2019-06-25
Q4 2017 -$12.7M -$2.87M -$231K -8.76% Oct 1, 2017 Dec 31, 2017 10-K 2019-06-25
Q3 2017 -$12.4M -$4.99M -$1.89M -61.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-06-25
Q2 2017 -$10.5M -$2.26M -$296K -15.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-06-25
Q1 2017 -$10.2M -$2.55M +$5.95M +70% Jan 1, 2017 Mar 31, 2017 10-K 2018-06-26
Q4 2016 -$16.2M -$2.64M -$495K -23.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-06-26
Q3 2016 -$15.7M -$3.1M +$2.29M +42.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-06-26
Q2 2016 -$18M -$1.96M -$143K -7.85% Apr 1, 2016 Jun 30, 2016 10-K 2018-06-26
Q1 2016 -$17.9M -$8.5M -$5.23M -159% Jan 1, 2016 Mar 31, 2016 10-K 2017-06-29
Q4 2015 -$12.6M -$2.14M -$1.03M -91.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-06-29
Q3 2015 -$11.6M -$5.39M -$4.27M -384% Jul 1, 2015 Sep 30, 2015 10-K 2017-06-29
Q2 2015 -$7.33M -$1.82M -$550K -43.3% Apr 1, 2015 Jun 30, 2015 10-K 2017-06-29
Q1 2015 -$6.78M -$3.28M -$2.21M -207% Jan 1, 2015 Mar 31, 2015 10-K 2016-06-24
Q4 2014 -$4.57M -$1.12M +$332K +22.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-06-24
Q3 2014 -$4.9M -$1.11M +$101K +8.31% Jul 1, 2014 Sep 30, 2014 10-K 2016-06-24
Q2 2014 -$5M -$1.27M +$29K +2.23% Apr 1, 2014 Jun 30, 2014 10-K 2016-06-24
Q1 2014 -$5.03M -$1.07M +$405K +27.5% Jan 1, 2014 Mar 31, 2014 10-K 2015-06-29
Q4 2013 -$5.43M -$1.45M +$471K +24.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-06-29
Q3 2013 -$5.91M -$1.22M +$467K +27.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-06-29
Q2 2013 -$6.37M -$1.3M +$421K +24.5% Apr 1, 2013 Jun 30, 2013 10-K 2015-06-29
Q1 2013 -$6.79M -$1.47M +$1.32M +47.2% Jan 1, 2013 Mar 31, 2013 10-K 2014-06-25
Q4 2012 -$8.11M -$1.92M +$933K +32.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-06-25
Q3 2012 -$9.04M -$1.68M +$123K +6.81% Jul 1, 2012 Sep 30, 2012 10-K 2014-06-25
Q2 2012 -$9.17M -$1.72M -$121K -7.56% Apr 1, 2012 Jun 30, 2012 10-K 2014-06-25
Q1 2012 -$9.04M -$2.79M -$72.3K -2.66% Jan 1, 2012 Mar 31, 2012 10-K 2013-07-18
Q4 2011 -$8.97M -$2.85M -$325K -12.9% Oct 1, 2011 Dec 31, 2011 10-K 2013-07-18
Q3 2011 -$8.65M -$1.81M -$943K -109% Jul 1, 2011 Sep 30, 2011 10-K 2013-07-18
Q2 2011 -$7.7M -$1.6M -$1.14M -247% Apr 1, 2011 Jun 30, 2011 10-K 2013-07-18
Q1 2011 -$6.56M -$2.71M Jan 1, 2011 Mar 31, 2011 10-K 2012-07-02
Q4 2010 -$2.53M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 -$862K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$461K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.